Alvotech
Latest news
Investors
02 May 2024
Alvotech Announces Participation at BofA Securities Healthcare Conference 2024
Investors
30 April 2024
U.S. Commercialization Agreement with Quallent to Drive Patient Savings with First High-Concentration Citrate-Free Interchangeable Biosimilar to Humira® (adalimumab)
Investors
24 April 2024